|Registration Rates||Early Bird||After 10/18/2013|
|Discounted OPA Member||$115||$145|
|Student/Resident (PGY1 or PGY2)||$45||$45|
|Registration and Continental Breakfast|
|8:30 a.m.||Drug Interactions Review|
|9:30 a.m.||Serving the Underserved|
|10:40 a.m.||Review of Ohio Pharmacy Law|
|12:30 p.m.||MS Update and Therapy|
|1:30 p.m.||Starting MTM Services|
|2:45 p.m.||Basics of Oral Contraceptives|
|3:45 p.m.||Opioids in Non-terminal Pain|
As drug interaction alerts continue to increase, it becomes even more important to know which interactions are clinically significant. This program will explain the differences between pharmacodynamic and pharmacokinetic interactions; medications and patients at high risk; and the role of the CYP 450 system in pharmacokinetic drug interactions.
Teresa Hoffmann, R.Ph., PharmD, CDE, CLS, BCPS, BCACP, Clinical Supervisor at the Medication Management Clinic, St. Rita’s Medical Center, Lima, OH.
ACPE #0129-0000-13-077-L01-P 0.1 CEU
Pharmacists are frequently asked to identify health resources for the poor in their area. This session will discuss types of poverty and the challenges those in poverty face; health care for the poor and models of care to address those challenges; the mental model of poverty; and available resources for health care professionals.
Alexa Sevin, R.Ph., PharmD, PGY2 Ambulatory Care Pharmacy Practice Resident, OSU, Columbus Neighborhood Health Centers; and Holly Fahey, R.Ph., PharmD, Manager of Clinical Operations and Experiential Education, The Charitable Pharmacy of Central Ohio
ACPE #0129-0000-13-078-L04-P 0.1 CEU
This session will discuss the legal requirements for dispensing controlled substances for weight loss, including the new drugs Qsymia® and Belviq®; faxed, electronic or e-scripts; documentation; partial filling; and the timing and use of OARRS reports to help detect drug diversion. The proper components of patient counseling, and legal requirements for selling syringes will also be discussed.
This program is approved for 0.1 CEU (one contact hour) of Ohio Board-approved jurisprudence CE.
Donald Sullivan, R.Ph, PhD, Professor of Pharmacy Practice, Ohio Northern University, College of Pharmacy
ACPE #0129-0000-13-079-L03-P 0.1 CEU Application-based activity
This presentation will discuss the etiology and pathophysiology of multiple sclerosis. Current and emerging approaches to treatment, including drug mechanism, dose, route, adverse effect(s), cost of patient care, and effective patient counseling, will be included.
Richard W. Dudley, R.Ph., PhD, Associate Professor, Department of Pharmaceutical Sciences, The University of Findlay, College of Pharmacy
ACPE #0129-0000-13-080-L01-P 0.1 CEU
Many pharmacists are interested and excited about starting MTM services, but don’t know where to begin. This presentation will follow one organization’s blueprint to implement MTM services from idea generation to business plan preparation, to identification of basics and key learning points along the way. This model will include pieces and parts applicable to many practice sites.
Chet Kaczor, R.Ph., PharmD, MBA, Manager, Ambulatory Pharmacy Services, and Emily Middleton, R.Ph., PharmD, Staff Pharmacist, Nationwide Children’s Hospital
ACPE #0129-0000-13-081-L04-P 0.1 CEU
This program will highlight the pharmacology of oral contraceptives (OCs), evaluate available OC products, and characterize which medications are most effective/acceptable in various patient populations. Our speaker will provide a good “101/Review” of oral contraceptives including pharmacology, therapeutics, and side effect profiles.
Ashley M. Sweaney, R.Ph., PharmD, Medication Management Specialist and Clinical Assistant Professor, OSU College of Pharmacy, Medication Management Program
ACPE #0129-0000-13-082-L01-P 0.1 CEU
Evidence exists for and against the use of chronic opioid therapy for non-terminal pain. This presentation will cover both, as well as the recently approved guidelines for prescribing opioids for chronic, non-terminal pain including the Morphine Equivalent Daily Dose (MED).
Amber Hartman, R.Ph., PharmD, Specialty Practice Pharmacist, Palliative Medicine, Arthur G. James Cancer Hospital, OSU
ACPE #0129-0000-13-083-L01-P 0.1 CEU
Your NABP e-Profile ID and birthdate must be provided to us in order to receive CE credit for this meeting. If you have not yet obtained this number, please log on to www.MyCPEmonitor.net and set up your NABP e-profile.
Continuing Education Credit
This meeting is targeted to all pharmacists. The continuing education for this program is coordinated by the Ohio Pharmacists Foundation (OPF). To receive continuing pharmacy education credit, you must complete the CE form indicating programs attended. Sign, date, and return the CE form to the OPA staff or office. Your CE credit will be uploaded to the CPE Monitor. Learning objectives for the continuing pharmacy education programs will be available on the OPA website at www.ohiopharmacists.org. All CE sessions are knowledge-based activities unless otherwise indicated. The Ohio Pharmacists Foundation adheres to ACPE Standards regarding industry support of continuing pharmacy education. Disclosure of faculty and commercial support relationships will be made known at the activity. Speakers are expected to openly disclose intent to discuss any off-label or investigational use of drugs, devices, or equipment in their presentations.
|The Ohio Pharmacists Foundation, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
Requests for refunds, less $15 administrative fee, will be honored if received by 11/1/2013.